Anti-IL17D/ IL27/ IL-17D functional antibody

Anti-IL17D/ IL27/ IL-17D functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to IL27/IL17D products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T41171-Ab-1/ GM-Tg-hg-T41171-Ab-2Anti-Human IL27/IL17D monoclonal antibodyHuman
GM-Tg-rg-T41171-Ab-1/ GM-Tg-rg-T41171-Ab-2Anti-Rat IL27/IL17D monoclonal antibodyRat
GM-Tg-mg-T41171-Ab-1/ GM-Tg-mg-T41171-Ab-2Anti-Mouse IL27/IL17D monoclonal antibodyMouse
GM-Tg-cynog-T41171-Ab-1/ GM-Tg-cynog-T41171-Ab-2Anti-Cynomolgus/ Rhesus macaque IL27/IL17D monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T41171-Ab-1/ GM-Tg-felg-T41171-Ab-2Anti-Feline IL27/IL17D monoclonal antibodyFeline
GM-Tg-cang-T41171-Ab-1/ GM-Tg-cang-T41171-Ab-2Anti-Canine IL27/IL17D monoclonal antibodyCanine
GM-Tg-bovg-T41171-Ab-1/ GM-Tg-bovg-T41171-Ab-2Anti-Bovine IL27/IL17D monoclonal antibodyBovine
GM-Tg-equg-T41171-Ab-1/ GM-Tg-equg-T41171-Ab-2Anti-Equine IL27/IL17D monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T41171-Ab-1/ GM-Tg-hg-T41171-Ab-2; GM-Tg-rg-T41171-Ab-1/ GM-Tg-rg-T41171-Ab-2;
GM-Tg-mg-T41171-Ab-1/ GM-Tg-mg-T41171-Ab-2; GM-Tg-cynog-T41171-Ab-1/ GM-Tg-cynog-T41171-Ab-2;
GM-Tg-felg-T41171-Ab-1/ GM-Tg-felg-T41171-Ab-2; GM-Tg-cang-T41171-Ab-1/ GM-Tg-cang-T41171-Ab-2;
GM-Tg-bovg-T41171-Ab-1/ GM-Tg-bovg-T41171-Ab-2; GM-Tg-equg-T41171-Ab-1/ GM-Tg-equg-T41171-Ab-2
Products NameAnti-IL27/IL17D monoclonal antibody
Formatmab
Target NameIL27
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IL27 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T41171-Ag-1Recombinant multi-species IL17D/ IL27/ IL-17D protein
    CytokineGM-Tg-g-T41171-Ag-1interleukin 17D (IL17D) protein
    ORF Viral VectorpGMLP003442human IL17D Lentivirus plasmid
    ORF Viral VectorvGMLP003442human IL17D Lentivirus particle


    Target information

    Target IDGM-T41171
    Target NameIL27
    Gene ID53342,239114,691799,721163,102156421,101093070,614982
    Gene Symbol and SynonymsIL-17D,IL17D
    Uniprot AccessionQ8TAD2
    Uniprot Entry NameIL17D_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target, Cytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000172458
    Target ClassificationN/A

    The target: IL27, gene name: IL17D, also named as IL-17D. The protein encoded by this gene is a cytokine that shares the sequence similarity with IL17. The treatment of endothelial cells with this cytokine has been shown to stimulate the production of other cytokines including IL6, IL8 and CSF2/ GM-CSF. The increased expression of IL8 induced by this cytokine was found to be NF-kappa B-dependent. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.